Modulation of the host's inflammatory response in bacterial meningitis may be beneficial. In this study, the effects of dexamethasone and HWA-138, an analog of pentoxifylline, on CSF cultures and cochlear inflammation in an infant rat model of Haemophilus influenzae type b were studied. Five-day-old infant rats were inoculated once intraperitoneally with 1 x 104 to 10 x i04 CFU of H. influenzae type b (strain 1406). Twenty-four hours later, infant rats were treated intraperitoneally with one dose of ampicillin (0.1 mg/g of body weight), cefotaxime (0.05 mg/g), or cefuroxime (0.05 mg/g) alone or in combination with one dose of dexamethasone (0.00015 mg/g) or HWA-138 (0.005 mg/g). Twenty-four hours after treatment with cefuroxime plus dexamethasone, animals had a significantly (P c 0.04) greater incidence of bacteremia and meningitis (eight of nine animals) than that in animals of the other treatment groups. Overall, dexamethasone was associated with less inflammation (P < 0.04) of the cochlear nerve compared with that from antibiotic treatment alone. In this model, when suboptimal antimicrobial therapy is administered, anti-inflammatory agents may be beneficial with respect to reducing cochlear inflammation. However, dexamethasone and cefuroxime lead to a higher rate of positive blood and cerebral spinal fluid cultures than cefuroxime alone.
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Modulation of the host's inflammatory response during bacterial meningitis may be beneficial since the pathogenesis of the neurologic sequelae relates, in part, to this reaction (14) . In experimental animals, dexamethasone and other anti-inflammatory agents administered adjunctively with antibiotics may result in diminished brain water content (cerebral edema), intracranial pressure, and lactate concentrations in cerebral spinal fluid (CSF), among other effects (19) (20) (21) (22) . Simultaneous administration of dexamethasone and ceftriaxone leads to decreased activity of tumor necrosis factor (TNF) and indices of meningeal inflammation in the CSF of rabbits with experimental Haemophilus influenzae type b meningitis compared with that in the CSF of animals treated with ceftriaxone alone (12) . In a randomized prospective study of dexamethasone versus placebo adjunctive therapy along with cefuroxime in childhood meningitis, a significant reduction in bilateral moderate or more severe hearing loss was demonstrated in children with H. influenzae type b meningitis who received dexamethasone (5). A similar but nonsignificant reduction was observed when ceftriaxone was used with dexamethasone in a second study. In those clinical studies, cytokine concentrations in CSF were also reduced in the dexamethasone-treated children (11) . Presumably, a reduction in inflammation within the cochlea or surrounding the eighth cranial nerve results in less likelihood of deafness in the children to whom dexamethasone is administered.
Pentoxifylline is a xanthine derivative which inhibits phosphodiesterases and is used widely to improve microcirculation in patients with chronic occlusive arterial disease. Several investigators have described the anti-inflammatory properties of pentoxifylline, such as modulation of neutro-phil adherence to endothelial cells as well as a decrease in superoxide production by neutrophils (9, 18) . Pentoxifylline also inhibits TNF activation of neutrophils, in addition to decreasing TNF production by macrophages stimulated by endotoxin (17) . In experimental models of gram-negative infection or endotoxemia, pretreatment or early treatment with pentoxifylline increases survival and decreases lung injury (6, 16, 23) . In the rabbit model of H. influenzae type b meningitis, pentoxifylline decreased protein and lactate concentrations in CSF when it was administered 30 min prior to ceftriaxone infusion (13) .
In a previous study (4), we were unable to demonstrate that dexamethasone added to antibiotic therapy resulted in any less inflammation within the cochlea than did antibiotic therapy alone. In that study, two doses of the antibiotics were administered prior to sacrifice of the animals. In CFU of H. influenzae type b. At 48 h, the infant rats were sacrificed with pentobarbital given i.p. In previous experiments, cochlear inflammation was found to be maximal at 48 h after inoculation (24) . CSF was collected by cisterna magna puncture, and blood was collected by cardiac puncture. CSF cell count was determined with a Spencer hemacytometer; CSF and blood were cultured on chocolate agar without the addition of cephalosporinase.
In order to determine antibiotic concentrations in CSF and serum, 5-day-old healthy infant rats were inoculated i.p. with 104 CFU of H. influenzae type b. Two days later, rats were treated with single i.p. doses of the following: (i) ampicillin at 0.1 mg/g of body weight (100 mg/kg); (ii) ampicillin at 0.1 mg/g plus dexamethasone at 0.00015 mg/g (0.15 mg/kg); (iii) ampicillin at 0.1 mg/g plus HWA-138 at 0.005 mg/g (5.0 mg/kg); (iv) cefotaxime at 0.05 mg/g (50 mg/kg); (v) cefotaxime at 0.05 mg/g plus dexamethasone at 0.00015 mg/g; (vi) cefotaxime at 0.05 mg/g plus HWA-138 at 0.005 mg/g; (vii) cefuroxime at 0.05 mg/g (50 mg/kg); (viii) cefuroxime at 0.05 mg/g plus dexamethasone at 0.00015 mg/g; and (ix) cefuroxime at 0.05 mg/g plus HWA-138 at 0.005 mg/g.
One hour after the administration of the medications listed above, animals were sacrificed and CSF and sera were obtained.
Bioassay for antibiotic concentrations. Ampicillin, cefotaxime, and cefuroxime were measured in sera and CSF by a modification of the bioassay method of Bennett et al. (2) . In antibiotic medium no. 1 (Difco Laboratories, Detroit, Mich.), ampicillin and cefuroxime were measured by using Bacillus subtilis (Subtilis Spore Suspension; Difco). Cefotaxime was measured by using Escherichia coli (MIC of cefotaxime, <0.1 p,g/ml). Treatment experiments. Five-day-old infant rats were inoculated with H. influenzae type b 1406. At 24 h, the infant rats were treated with one dose of ampicillin (0.1 mg/g), cefotaxime (0.05 mg/g), or cefuroxime (0.05 mg/g) alone or in combination with one dose of dexamethasone (0.00015 mg/g) or HWA-138 (0.005 mg/g). The dose of HWA-138 was determined on the basis of experiments conducted by Luke et al. (7) in adult rats infected with Candida albicans. All medications were given i.p. Each qf the treatment options was administered to at least one infant rat in each litter.
Histologic examination. For light microscopy, one half of each rat head was placed in 10% buffered formalin. As described previously (24) , hematoxylin-and eosin-stained tissues were scored for any degree of inflammation of the inner ear by one investigator (E.P.H.), who was unaware of which treatment regimen was administered. The second half of each head was frozen at -70°C immediately after the rats were killed and was subsequently stained with a fluoresceinlabeled rabbit antiserum to whole H. influenzae type b. Sections were counterstained with 0.1% Evans blue dye and examined with a fluorescence microscope. Only three heads per group were selected for histologic examination.
Anglysis. Differences among the groups for inflammation
and bacterial detection in the cochlea, blood, and CSF cultures were determined by Fisher's exact test. The leukocyte counts in CSF were compared by using the analysis of variance on logarithmically transformed data.
RESULTS
Antibiotic concentrations or penetrations were not diminished in CSF when dexamethasone or HWA-138 was added to the treatment in infected animals ( Table 1 ).
All untreated animals (control) had positive blood and CSF cultures at 48 h. The cefuroxime and dexamethasone (Tables 2 and 3) . No significant differences were noted in the leukocyte count in CSF among the groups treated with antibiotic alone or antibiotic plus dexamethasone or HWA-138 (Table 4) .
Histologic analysis of the inner ear. The groups treated with antibiotic and dexamethasone showed a significant decrease in the incidence of inflammation at the, nerve level when compared with the incidence in the groups treated with antibiotic alone (P c 0.04), but it was no different than that in the groups treated with antibiotic plus HWA-138. There was a tendency for the antibiotic plus dexamethasone therapy to induce less of an inflammatory response of the cochlea at all levels. The presence of bacteria was similar whether or not the animals received dexamethasone or HWA-138 ( centrations bf TNF in CSF were observed in the group treated with pentoxifylline as well. In adult rats, pentoxifylline administered at a 20-mg/kg dose i.p. 1 h after intracisternal inoculation of H. influenzae type b lipooligosaccharide resulted in a significant reduction in blood-brain barrier permeability compared with that in controls (3). Pentoxifylline and HWA-138 both protected neonatal mice from experimental Staphylococcus aureus infection, although high doses of either were detrimental to the animals (8).
Pentoxifylline has been studied in adult volunteers infused intravenously with 100 mg of endotoxin prepared from Salmonella abortus equi on two occasions (25) . Saline or pentoxifylline (500 mg) was started 30 min prior to endotoxin administration, and the infusion was continued for 4 h. Pentoxifylline blunted the rise of TNF concentrations in serum, which peaked at 2 h in the saline treatment experiments. Interleukin-6 concentrations were not affected. These findings are consistent with those of in vitro experiments that indicated that pentoxifylline blocks TNF production in macrophage cultures.
We examined the effects of dexamethasone and HWA-138, an analog of pentoxifylline with similar activity but with a more prolonged half-life in neonatal mice compared with the half-life of the parent compound, in an infant rat model of H. influenzae type b meningitis that focused on inner ear inflammation. In this model, when two doses of antibiotics were administered 24 h after bacterial inoculation and on the day prior to sacrifice, we were unable to demonstrate less inflammation of the cochlea in animals treated with dexamethasone plus antibiotics compared with that in animals receiving antibiotics alone (4). This was due to the fact that two doses of antibiotics virtually eliminated cochlear inflammation in treated animals compared with that in untreated animals 48 h into the infection. In the experiments described here, only one dose of an antibiotic was administered, so that some difference as a result of administration of an anti-inflammatory agent may have been detected more readily.
The antibiotic concentrations achieved in the serum of infected infant rats were roughly equivalent to those observed in children following intravenous infusion. However, we found that for infant rats treated with cefuroxime and dexamethasone, significantly more blood and CSF cultures were positive for H. influenzae type b than was found for animals treated with ampicillin or cefotaxime plus dexamethasone. Animals receiving cefuroxime alone or with HWA-138 also were more likely to remain bacteremic or have positive CSF cultures 24 h after treatment than ampicillin-or cefotaxime-treated animals were, but these differences were not significant. Three animals per treatment group underwent histologic examination of the inner ear. In aggregate, there was less cochlear inflammation detected in the animals receiving the combinations of antibiotics plus an anti-inflammatory agent compared with that detected in animals receiving antibiotic treatment alone; dexamethasone and HWA-138 were equivalent in this regard.
The findings in this study are consistent with the clinical observation that delayed sterilization of CSF in H. influenzae type b meningitis is more common with cefuroxime than it is with several other antibiotics. The addition of dexamethasone to cefuroxime therapy resulted in an even more striking increase in blood and CSF cultures which remained positive, a finding again consistent with previous clinical observations. Concentrations of antibiotics in CSF were not diminished by either dexamethasone or HWA-138. When only one dose of an antibiotic was administered, both dexamethasone and HWA-138 adjunctive therapy were associated with decreased cochlear inflammation. Thus, when suboptimal antibiotic therapy is administered in this model, anti-inflammatory agents prove to be somewhat beneficial with respect to reducing inner ear inflammation. This may explain the beneficial effect of dexamethasone when it is administered to children who are treated with cefuroxime for H. influenzae type b meningitis (5) .
